S&P 500   4,447.30 (-0.18%)
DOW   34,951.28 (+0.44%)
QQQ   369.42 (-1.05%)
AAPL   145.05 (-1.27%)
MSFT   293.87 (-1.83%)
FB   351.02 (-0.55%)
GOOGL   2,821.72 (-0.79%)
TSLA   793.20 (+2.43%)
AMZN   3,373.97 (-1.50%)
NVDA   214.71 (-2.76%)
BABA   148.24 (+2.18%)
NIO   36.33 (+2.69%)
CGC   14.71 (+5.75%)
GE   106.06 (+2.18%)
MU   75.02 (+1.31%)
AMD   107.16 (+1.29%)
T   27.62 (+1.81%)
F   14.23 (+3.27%)
ACB   6.39 (+7.39%)
DIS   178.79 (+1.59%)
PFE   43.75 (-0.43%)
BA   226.24 (+2.19%)
BAC   43.34 (+2.85%)
S&P 500   4,447.30 (-0.18%)
DOW   34,951.28 (+0.44%)
QQQ   369.42 (-1.05%)
AAPL   145.05 (-1.27%)
MSFT   293.87 (-1.83%)
FB   351.02 (-0.55%)
GOOGL   2,821.72 (-0.79%)
TSLA   793.20 (+2.43%)
AMZN   3,373.97 (-1.50%)
NVDA   214.71 (-2.76%)
BABA   148.24 (+2.18%)
NIO   36.33 (+2.69%)
CGC   14.71 (+5.75%)
GE   106.06 (+2.18%)
MU   75.02 (+1.31%)
AMD   107.16 (+1.29%)
T   27.62 (+1.81%)
F   14.23 (+3.27%)
ACB   6.39 (+7.39%)
DIS   178.79 (+1.59%)
PFE   43.75 (-0.43%)
BA   226.24 (+2.19%)
BAC   43.34 (+2.85%)
S&P 500   4,447.30 (-0.18%)
DOW   34,951.28 (+0.44%)
QQQ   369.42 (-1.05%)
AAPL   145.05 (-1.27%)
MSFT   293.87 (-1.83%)
FB   351.02 (-0.55%)
GOOGL   2,821.72 (-0.79%)
TSLA   793.20 (+2.43%)
AMZN   3,373.97 (-1.50%)
NVDA   214.71 (-2.76%)
BABA   148.24 (+2.18%)
NIO   36.33 (+2.69%)
CGC   14.71 (+5.75%)
GE   106.06 (+2.18%)
MU   75.02 (+1.31%)
AMD   107.16 (+1.29%)
T   27.62 (+1.81%)
F   14.23 (+3.27%)
ACB   6.39 (+7.39%)
DIS   178.79 (+1.59%)
PFE   43.75 (-0.43%)
BA   226.24 (+2.19%)
BAC   43.34 (+2.85%)
S&P 500   4,447.30 (-0.18%)
DOW   34,951.28 (+0.44%)
QQQ   369.42 (-1.05%)
AAPL   145.05 (-1.27%)
MSFT   293.87 (-1.83%)
FB   351.02 (-0.55%)
GOOGL   2,821.72 (-0.79%)
TSLA   793.20 (+2.43%)
AMZN   3,373.97 (-1.50%)
NVDA   214.71 (-2.76%)
BABA   148.24 (+2.18%)
NIO   36.33 (+2.69%)
CGC   14.71 (+5.75%)
GE   106.06 (+2.18%)
MU   75.02 (+1.31%)
AMD   107.16 (+1.29%)
T   27.62 (+1.81%)
F   14.23 (+3.27%)
ACB   6.39 (+7.39%)
DIS   178.79 (+1.59%)
PFE   43.75 (-0.43%)
BA   226.24 (+2.19%)
BAC   43.34 (+2.85%)
NYSE:BAK

Braskem Stock Forecast, Price & News

$21.71
+0.03 (+0.14 %)
(As of 09/27/2021 12:16 PM ET)
Add
Compare
Today's Range
$21.66
$22.10
50-Day Range
$19.91
$26.69
52-Week Range
$7.00
$26.93
Volume7,822 shs
Average Volume267,371 shs
Market Capitalization$8.65 billion
P/E Ratio4.93
Dividend YieldN/A
Beta1.66
30 days | 90 days | 365 days | Advanced Chart
Receive BAK News and Ratings via Email

Sign-up to receive the latest news and ratings for Braskem and its competitors with MarketBeat's FREE daily newsletter.


Braskem logo

About Braskem

Braskem SA engages in the manufacture of petrochemicals and other related products. It operates through the following segments: Brazil, USA, and Europe and Mexico. The Brazil segment includes production and sale of chemicals, supply of electricity, and production and sale of PE. The USA and Europe segment involves production, operation, and sale of polypropylene in the United States and Germany. The Mexico segment comprises production, operation, and sale of ethylene, high-density polyethylene and low-density polyethylene in Mexico. The company was founded in August 2002 and is headquartered in Butanta, Brazil.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.34 out of 5 stars

Oils/Energy Sector

263rd out of 345 stocks

Industrial Organic Chemicals Industry

22nd out of 23 stocks

Analyst Opinion: 1.3Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Braskem (NYSE:BAK) Frequently Asked Questions

Is Braskem a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Braskem in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Braskem stock.
View analyst ratings for Braskem
or view top-rated stocks.

What stocks does MarketBeat like better than Braskem?

Wall Street analysts have given Braskem a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Braskem wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Braskem's next earnings date?

Braskem is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for Braskem
.

How were Braskem's earnings last quarter?

Braskem S.A. (NYSE:BAK) issued its quarterly earnings results on Tuesday, August, 3rd. The company reported $3.52 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.22 by $1.30. Braskem had a net margin of 11.24% and a negative trailing twelve-month return on equity of 811.92%.
View Braskem's earnings history
.

How has Braskem's stock price been impacted by Coronavirus (COVID-19)?

Braskem's stock was trading at $9.21 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BAK stock has increased by 135.7% and is now trading at $21.71.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for BAK?

6 analysts have issued 12 month price targets for Braskem's stock. Their forecasts range from $14.00 to $32.00. On average, they anticipate Braskem's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 1.3% from the stock's current price.
View analysts' price targets for Braskem
or view top-rated stocks among Wall Street analysts.

Who are Braskem's key executives?

Braskem's management team includes the following people:
  • Roberto Lopes Pontes Simões, Chief Executive Officer & Director
  • Pedro van Langendonck de Freitas, CFO, Head-Procurement & Institutional Relation
  • Daniel Sales Corrêa, Head-Investments & Digital Technologies
  • Artur Faria, Director-M&A, Business Development
  • Marcelo Arantes de Carvalho, Head-People, Communications & Marketing

What is Roberto Lopes Pontes Simões' approval rating as Braskem's CEO?

31 employees have rated Braskem CEO Roberto Lopes Pontes Simões on Glassdoor.com. Roberto Lopes Pontes Simões has an approval rating of 100% among Braskem's employees. This puts Roberto Lopes Pontes Simões in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Braskem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Braskem investors own include Amarin (AMRN), Enterprise Products Partners (EPD), Micron Technology (MU), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Aduro Biotech (ADRO), Armata Pharmaceuticals (ARMP), CRISPR Therapeutics (CRSP) and Chevron (CVX).

What is Braskem's stock symbol?

Braskem trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAK."

Who are Braskem's major shareholders?

Braskem's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (0.19%), Dimensional Fund Advisors LP (0.17%), JPMorgan Chase & Co. (0.05%), State Street Corp (0.04%), Renaissance Technologies LLC (0.02%) and Bank of Nova Scotia (0.01%).

Which major investors are selling Braskem stock?

BAK stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Citadel Advisors LLC, State Street Corp, Vanguard Group Inc., Dimensional Fund Advisors LP, and Goldman Sachs Group Inc..

Which major investors are buying Braskem stock?

BAK stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Bank of Nova Scotia, Invesco Ltd., TCW Group Inc., Renaissance Technologies LLC, Jump Financial LLC, Veriti Management LLC, and Comerica Bank.

How do I buy shares of Braskem?

Shares of BAK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Braskem's stock price today?

One share of BAK stock can currently be purchased for approximately $21.71.

How much money does Braskem make?

Braskem has a market capitalization of $8.65 billion and generates $11.37 billion in revenue each year. The company earns $-1,298,190,000.00 in net income (profit) each year or ($3.26) on an earnings per share basis.

How many employees does Braskem have?

Braskem employs 7,993 workers across the globe.

What is Braskem's official website?

The official website for Braskem is www.braskem.com.br.

Where are Braskem's headquarters?

How can I contact Braskem?

Braskem's mailing address is Rua Lemos Monteiro 120 24 andar, Butanta D5, 05501-050. The company can be reached via phone at 551135769735 or via email at [email protected].


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.